Thymopetidum

胸腺肽

Report date: 2022/06/13 11:46:41

Base Information

Drug NameThymopetidum
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsImmunologic Deficiency Syndromes
Approved Indications in ChinaImmunologic Deficiency Syndromes
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeL03AX09
Related LinksN/A